Motus Gi Holdings AI Stock Analysis
Want to see MOTS full AI Analyst Report?
Motus Gi Holdings (MOTS) AI Stock Analysis
Motus Gi Holdings
(Other OTC:MOTS)
Motus Gi Holdings faces significant financial instability with declining revenues, consistent net losses, and negative cash flows. The absence of technical analysis data and a negative P/E ratio suggest continued challenges in market performance and profitability. The lack of earnings call guidance exacerbates uncertainty, leading to a low overall stock score.
Motus Gi Holdings (MOTS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1,278
- Dividend Yield
- ―
- Average Volume (3M)
- 1,005
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- 413.08
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 15
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Motus Gi Holdings Business Overview & Revenue Model
Company Description
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper g...
How the Company Makes Money
Motus GI Holdings generates revenue primarily through the sale and distribution of its Pure-Vu System and related accessories. The company targets hospitals and clinics that perform colonoscopies, promoting the Pure-Vu System as a means to optimize p...
Motus Gi Holdings Risk Analysis
Motus Gi Holdings disclosed 61 risk factors in its most recent earnings report. Motus Gi Holdings reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskMotus Gi Holdings Peers Comparison
Overall Rating
AEMD44Neutral
BMRA42Neutral
PAVM42Neutral
MOTS38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | $8.15M | -0.47 | -141.22% | ― | ― | 90.69% | |
| 42Neutral | $5.68M | -0.79 | -142.81% | ― | -11.20% | -6.64% | |
| 42Neutral | $12.07M | -0.16 | -58.07% | ― | 410.34% | -185.92% | |
| 38Underperform | $1,278 | 0.00 | -454.34% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MOTS | Motus Gi Holdings | 0.01 | 0.00 | 0.00% | |
| BMRA | Biomerica Inc | 1.24 | -0.95 | -43.35% | |
| AEMD | Aethlon | 5.08 | -13.77 | -73.05% | |
| PAVM | Pavmed | 1.51 | -10.09 | -86.98% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jan 03, 2025
